Understanding human-derived antibodies generated by polymorphic malaria vaccine against merozoite surface protein 2
File(s)jiy171.pdf (182.26 KB)
Accepted version
Author(s)
Angrisano, Fiona
Blagborough, Andrew M
Type
Journal Article
Date Issued
2018-06-05
Date Acceptance
2018-03-21
Citation
Journal of Infectious Diseases, 2018, 218 (1), pp.5-6
ISSN
0022-1899
Publisher
Oxford University Press (OUP)
Start Page
5
End Page
6
Journal / Book Title
Journal of Infectious Diseases
Volume
218
Issue
1
Copyright Statement
© 2018 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. This is a pre-copy-editing, author-produced version of an article accepted for publication in The Journal of Infectious Diseases following peer review. The definitive publisher-authenticated version is available online at: https://dx.doi.org/10.1093/infdis/jiy171
Sponsor
Medical Research Council (MRC)
Bill & Melinda Gates Foundation
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/29584870
PII: 4952403
Grant Number
MR/N00227X/1
n/a
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
Infectious Diseases
Microbiology
MSP2
vaccine
malaria
IMMUNITY
11 Medical And Health Sciences
06 Biological Sciences
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2018-03-23